ArticleBMC biotechnology2023

A fully human connective tissue growth factor blocking monoclonal antibody ameliorates experimental rheumatoid arthritis through inhibiting angiogenesis.

Yang Qin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.